Roche Offers $5.7 Billion for Gene Company Illumina

Swiss drug giant Roche Holding Ltd. made a hostile offer for Illumina Inc. that values the DNA sequencing company at $5.7 billion, in a move that underscores growing interest in the competitive field of gene sequencing.

Source: The Wall Street Journal